How Cinfa is advancing therapeutic relevance in Middle East

Over the past decade, Cinfa, a leading Spanish pharmaceutical company, has strategically built one of its most significant international footprints in the Middle East. Today, the region represents approximately 80 percent of Cinfa’s international revenue, making it the company’s most important international market and reflecting more than 12 years of sustained growth and commitment to local healthcare systems. Since entering the UAE in 2013, the company has expanded its presence across the GCC,

This story was originally reported by Arab News. As an automated real-time news aggregator, NewsToolBar provides multi-perspective indexing and AI summarization while directing full readership directly to primary publisher sources.